Moreover, Opn expression correlates with disease progression in NASH patients [38] and co-localized with c-Jun in hepatocytes and NPLCs of NASH patients, strongly suggesting that the genetic links observed here in mice also apply to human disease. The gene discussed is SPP1; the disease is metabolic dysfunction-associated steatohepatitis.